Spika Lifescience Private Limited
About Spika Lifescience Private Limited
Data last updated:
Spika Lifescience Private Limited is a private limited company based in Vellore, Tamil Nadu, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 25 February 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2013PTC089743. Its GSTIN is 33AASCS8709F1ZZ (Tamil Nadu).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.1 Lakh. It is led by directors including Kannan Narendran (Managing Director) and Basavaraj Bhavanisankar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.532/2 Tnhb Phase – 3 Sathuvachari, Vellore, Tamil Nadu, India – 632009.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.23 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹89,528 (net margin 0.7%) and EBITDA of ₹26.53 Lakh (EBITDA margin 21.6%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spika Lifescience Private Limited's registered office is in Vellore, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.532/2 Tnhb Phase – 3 Sathuvachari, Vellore, Tamil Nadu, India – 632009
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Spika Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spika Lifescience is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Spika Lifescience Private Limited, buy the company report.
Financials of Spika Lifescience Private Limited
FY 2025 filings availableSpika Lifescience Private Limited reported revenue of ₹1.23 Cr (down 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 20% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹89,528 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.6% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spika Lifescience Private Limited, buy the company report.
Board of directors of Spika Lifescience Private Limited
Spika Lifescience has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannan Narendran | Managing Director | 25 Feb 2013 | 13 Years 8 Months | Current |
| Basavaraj Bhavanisankar | Director | 25 Feb 2013 | 13 Years 8 Months | Current |
| Jeyaraman Balaji | Director | 25 Feb 2013 | 13 Years 8 Months | Current |
Peer comparison
Spika Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Royal Spares & Accessories Private Limited | ₹1.23 Cr (FY 2025) | -82.0% | Berhampur, Odisha, India | |||
| Geoffroi Labs Private Limited | ₹1.23 Cr (FY 2025) | 6.0% | Gwalior, Madhya Pradesh, India | |||
| Fridaylines Private Limited | ₹1.23 Cr (FY 2025) | -9.0% | Changanacherry, Kerala, India | |||
| Ifox Infra Private Limited | ₹1.23 Cr (FY 2024) | -57.0% | Udumalpet, Tamil Nadu, India | |||
| Consociate Impex Private Limited | ₹1.23 Cr (FY 2025) | 52.0% | Kolkata, West Bengal, India | |||
| Spika Lifescience Private Limitedthis company | ₹1.23 Cr (FY 2024) | ₹89,528 | 0.7% | -20.0% | Vellore, Tamil Nadu, India | |
| Kumar Polycot Mills Limited | ₹1.23 Cr (FY 2025) | -79.0% | Coimbatore, Tamil Nadu, India | |||
| Ultraadox Private Limited | ₹1.23 Cr (FY 2024) | 14862.0% | Bangalore, Karnataka, India | |||
| Sindhiya Natural Foods Private Limited | ₹1.23 Cr (FY 2017) | 61.0% | Thane, Maharashtra, India | |||
| Kisan Disha Producer Company Limited | ₹1.23 Cr (FY 2025) | 90.0% | Hingoli, Maharashtra, India | |||
| Kavungal Distributors Private Limited | ₹1.23 Cr (FY 2017) | Thrissur, Kerala, India |
To see the full peer comparison of Spika Lifescience Private Limited, buy the company report.
Auditor
Spika Lifescience Private Limited is audited by KUMAR AMIT for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR AMIT | FY 2016 | 159419 |
Shareholding
The shareholding of Spika Lifescience Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Spika Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spika Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spika Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spika Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AASCS8709F1ZZ | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spika Lifescience Private Limited, buy the company report.
Recent activity
Spika Lifescience Private Limited has 5 board changes on record since 2013: 3 appointments and 2 cessations. The latest: Antoniswamy Felix Arokiaraj ceased to be Director on 30 Aug 2023.
Frequently asked questions
Spika Lifescience is an active private limited company based in Vellore, Tamil Nadu, India. The company works in other wholesale, within the trading industry. It was incorporated on 25 February 2013 (13+ years old) and is registered under CIN U74900TN2013PTC089743.
Spika Lifescience has 3 current directors:
- Kannan Narendran - Managing Director
- Basavaraj Bhavanisankar - Director
- Jeyaraman Balaji - Director
The latest financial statements of Spika Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Spika Lifescience is 33AASCS8709F1ZZ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Spika Lifescience is U74900TN2013PTC089743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spika Lifescience was incorporated on 25 February 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Spika Lifescience by revenue are Royal Spares & Accessories Private Limited, Geoffroi Labs Private Limited, Fridaylines Private Limited, Ifox Infra Private Limited, Consociate Impex Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Antoniswamy Felix Arokiaraj ceased to be Director on 30 Aug 2023. Marimuthu Kalicharan ceased to be Director on 06 Apr 2018. Basavaraj Bhavanisankar was appointed as Director on 25 Feb 2013. Spika Lifescience has 5 board changes on record in total.
The registered office of Spika Lifescience is at No.5322 Tnhb Phase – 3 Sathuvachari, Vellore, Tamil Nadu, India – 632009.
Spika Lifescience operates in the trading industry, in the other wholesale segment.
The compliance status of Spika Lifescience is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.